Arondite | $12,000,000 | (May 2, 2025)
SafeHeal | $39,548,022 | (May 2, 2025)
Ceto | $4,800,000 | (May 2, 2025) Certified by Founder
Lodge
T-Therapeutics Ltd
start up
United Kingdom
- Cambridge
- 16/11/2023
- Series A
- $59,707,000
T-Therapeutics is a next-generation TCR company, spun out from the University of Cambridge, deeply rooted in world-leading academic science. We are developing ‘optimal’ TCR based therapeutics using our proprietary OpTiMus® platform, based on a fully humanized TCR mouse that provides an almost unlimited source of unique, antigen-specific human TCRs.
We combine world-leading expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration.
- Industry Biotechnology Research
- Website https://t-therapeutics.com/
- LinkedIn https://www.linkedin.com/company/t-therapeutics/about/
Peek(US) | $5,000,000 | (May 2, 2025)
Paramark.com | $8,000,000 | (May 2, 2025)
Zoe Financial | $30,000,000 | (May 2, 2025)
Stately Bio | $12,000,000 | (May 2, 2025)
QbDVision | $13,000,000 | (May 2, 2025)
Blacksmith | $3,500,000 | (May 2, 2025)
Persona | $200,000,000 | (May 1, 2025)